Company
Australian Clinical Labs Ltd
Headquarters: Clayton, VIC, Australia
CEO: Ms. Melinda McGrath
Market Cap
A$514.7 Million
AUD as of July 1, 2024
US$342.8 Million
Australian Clinical Labs Ltd Categories
Australia Healthcare Diagnostics & ResearchAustralia Healthcare Australia Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $204.45 B |
| Danaher | $177.21 B |
| Siemens Healthineers AG | $63.84 B |
| DexCom, Inc. | $45.21 B |
| Lonza Group Ltd | $39.85 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Australian Clinical Labs Limited provides pathology services. The company offers various routine pathology tests, advanced pathology, first trimester screening and non-invasive prenatal testing, chemical pathology, hematology, histopathology, immunology, serology and microbiology, functional pathology, and commercial drug and alcohol testing services. The company offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is based in Clayton, Australia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Australian Clinical Labs Ltd has the following listings and related stock indices.
Stock: ASX: ACL wb_incandescent